Micro Systemation AB Series B
Micro Systemation AB (publ), together with its subsidiaries, provides forensic technology for mobile device examination and analysis in Sweden and internationally. The company offers XRY software products that include XRY logical, a software solution that enables investigators to access and recover live and file system data from the device on the crime scene; XRY Physical, a software solution, wh… Read more
Micro Systemation AB Series B (0FBM) - Total Liabilities
Latest total liabilities as of December 2021: Skr115.70 Million SEK
Based on the latest financial reports, Micro Systemation AB Series B (0FBM) has total liabilities worth Skr115.70 Million SEK as of December 2021.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Micro Systemation AB Series B - Total Liabilities Trend (2017–2021)
This chart illustrates how Micro Systemation AB Series B's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Micro Systemation AB Series B Competitors by Total Liabilities
The table below lists competitors of Micro Systemation AB Series B ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
San Lien Technology
TWO:5493
|
Taiwan | NT$2.82 Billion |
|
FLITTO Inc
KQ:300080
|
Korea | ₩10.93 Billion |
|
Biosyent Inc.
PINK:BIOYF
|
USA | $7.88 Million |
|
Canyon Resources Ltd
AU:CAY
|
Australia | AU$6.50 Million |
|
Windlas Biotech Limited
NSE:WINDLAS
|
India | ₹2.80 Billion |
|
Imagicaaworld Entertainment Limited
NSE:IMAGICAA
|
India | ₹5.48 Billion |
|
ShareHope Medicine Co Ltd
TWO:8403
|
Taiwan | NT$2.75 Billion |
Liability Composition Analysis (2017–2021)
This chart breaks down Micro Systemation AB Series B's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.68 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 1.27 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.56 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Micro Systemation AB Series B's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Micro Systemation AB Series B (2017–2021)
The table below shows the annual total liabilities of Micro Systemation AB Series B from 2017 to 2021.
| Year | Total Liabilities | Change |
|---|---|---|
| 2021-12-31 | Skr115.70 Million | +15.20% |
| 2020-12-31 | Skr100.43 Million | -11.96% |
| 2019-12-31 | Skr114.08 Million | +38.42% |
| 2018-12-31 | Skr82.41 Million | -3.77% |
| 2017-12-31 | Skr85.64 Million | -- |